Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
1.200
0.00 (0.01%)
Nov 21, 2024, 1:05 PM EST - Market open
Plus Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 5.73 | 4.91 | 0.22 | - | 0.3 | 7 | Upgrade
|
| Revenue Growth (YoY) | 52.63% | 2093.30% | - | - | -95.67% | 134.60% | Upgrade
|
| Cost of Revenue | 2.79 | 9.69 | 9.7 | 5.32 | 2.7 | 5.37 | Upgrade
|
| Gross Profit | 2.93 | -4.78 | -9.47 | -5.32 | -2.4 | 1.63 | Upgrade
|
| Selling, General & Admin | 9.19 | 8.54 | 10.24 | 6.85 | 6.41 | 5.29 | Upgrade
|
| Operating Expenses | 17.58 | 8.54 | 10.24 | 6.85 | 6.41 | 5.29 | Upgrade
|
| Operating Income | -14.65 | -13.32 | -19.71 | -12.18 | -8.8 | -3.66 | Upgrade
|
| Interest Expense | -0.18 | -0.4 | -0.71 | -0.93 | -1.11 | -1.86 | Upgrade
|
| Interest & Investment Income | 0.33 | 0.4 | 0.15 | 0.02 | 0.05 | 0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.62 | - | 0 | 0.01 | 2.4 | 2.17 | Upgrade
|
| EBT Excluding Unusual Items | -12.89 | -13.32 | -20.28 | -13.08 | -7.46 | -3.28 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0.07 | - | - | Upgrade
|
| Pretax Income | -12.89 | -13.32 | -20.28 | -13.4 | -8.24 | -3.28 | Upgrade
|
| Earnings From Continuing Operations | -12.89 | -13.32 | -20.28 | -13.4 | -8.24 | -3.28 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -7.6 | Upgrade
|
| Net Income | -12.89 | -13.32 | -20.28 | -13.4 | -8.24 | -10.89 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.55 | Upgrade
|
| Net Income to Common | -12.89 | -13.32 | -20.28 | -13.4 | -8.24 | -11.44 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 3 | 2 | 1 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 3 | 2 | 1 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 125.30% | 79.45% | 117.18% | 173.03% | 219.93% | 696.09% | Upgrade
|
| EPS (Basic) | -2.22 | -4.24 | -11.58 | -16.63 | -27.92 | -124.00 | Upgrade
|
| EPS (Diluted) | -3.09 | -4.24 | -11.58 | -16.65 | -27.92 | -124.00 | Upgrade
|
| Free Cash Flow | -11.4 | -13.01 | -13.48 | -10.42 | -8.53 | -5.97 | Upgrade
|
| Free Cash Flow Per Share | -1.97 | -4.14 | -7.70 | -12.93 | -28.89 | -64.74 | Upgrade
|
| Gross Margin | 51.20% | -97.23% | - | - | - | 23.34% | Upgrade
|
| Operating Margin | -255.95% | -271.14% | -8800.00% | - | -2905.28% | -52.26% | Upgrade
|
| Profit Margin | -225.07% | -271.04% | -9051.34% | - | -2719.80% | -163.49% | Upgrade
|
| Free Cash Flow Margin | -199.14% | -264.83% | -6018.30% | - | -2814.19% | -85.35% | Upgrade
|
| EBITDA | -13.98 | -12.69 | -19.09 | -11.78 | -8.44 | -3.23 | Upgrade
|
| EBITDA Margin | -244.16% | -258.36% | - | - | - | -46.13% | Upgrade
|
| D&A For EBITDA | 0.68 | 0.63 | 0.62 | 0.4 | 0.37 | 0.43 | Upgrade
|
| EBIT | -14.65 | -13.32 | -19.71 | -12.18 | -8.8 | -3.66 | Upgrade
|
| EBIT Margin | -255.95% | -271.14% | - | - | - | -52.26% | Upgrade
|
| Revenue as Reported | - | - | - | - | 0.3 | 7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.